AstraZeneca Allowed to Resume Covid Vaccine Trial in U.S.

AstraZeneca  (AZN) – Get Report won government approval to continue the Phase 3 trial of its COVID-19 vaccine candidate, according to a report Friday.

The U.S. Food and Drug Administration contacted the company Friday to let it know it can resume the study in the U.S., the Wall Street Journal reported citing sources. 

AstraZeneca’s trial was placed on pause in the U.S. after a volunteer developed unexplained neurological symptoms in the U.K. trial. The U.K trial has already been resumed. 

AstraZeneca’s vaccine candidate is one of four coronavirus vaccine candidates in late-stage development in the U.S. 

Source link

error: Content is protected !!

New Report